Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page
- Check2 days agoChange DetectedThe new screenshot shows only minor UI updates and wording changes on the Study Details page, with no alterations to core data such as eligibility criteria, enrollment, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a government funding lapse notice and a new version tag (v3.2.0), replacing the old v3.1.0; this changes the core content and indicates updated operating status guidance.SummaryDifference5%

- Check31 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check45 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the Back to Top element was removed. Overall, this is a minor update with no changes to core content, pricing, or availability.SummaryDifference0.3%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check59 days agoChange DetectedThe web page has undergone significant updates, including the addition of new resources related to genetic and rare diseases, specifically focusing on polymyositis and dermatomyositis, while removing previous references to idiopathic inflammatory myopathy and inclusion body myositis.SummaryDifference5%

Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.